Delivery Order SPE2DB20D1100-SPE2DB25FC9V7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units) on August 27, 2025, with a ceiling value of $1,535.39 and an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procedures. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,605.05 on October 28, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of October 29, 2025, and represents a routine pharmaceutical procurement supporting federal medical supply needs. The place of performance is the vendor's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $76,733.23 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed price contract. The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $1,448.64 to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on April 21, 2025, with an ultimate completion date of April 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,818.29 to AmerisourceBergen Drug Corp for the supply of Janumet 50-500 mg tablets (180-count package) on November 5, 2025, with completion scheduled for November 6, 2025. This non-set-aside, competitively awarded contract operates under a firm fixed price structure and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,610.07 to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 17, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,823.85 on August 12, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count). This competitively awarded, firm fixed-price delivery order is expected to be completed by August 13, 2025, with fulfillment occurring at the vendor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among all eligible vendors. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a contract ceiling value of $4,393.68. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion on July 23, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a ceiling value of $1,224.07. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and was competitively awarded without set-aside provisions. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,095.60 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180 count) under a firm fixed price contract type. The award was made on June 2, 2025, with an ultimate completion date of June 3, 2025, and represents a non-competitive set-aside. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC9V7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,359.20 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units). This competitively awarded, firm fixed-price delivery order was issued on June 18, 2025, with an ultimate completion date of June 20, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a primary pharmaceutical distributor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems and the Defense Health Agency. The Janumet order represents a routine pharmaceutical supply transaction within this strategic contract vehicle, which enables the company to fulfill diverse federal medical supply requirements across multiple therapeutic domains on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 6/18/25 |